1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Allergy Treatment Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Allergy Treatment Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Allergy Cases Accelerate Demand for Anti-Allergic Drugs to Favor Market
5.2 Market Opportunities
- 5.2.1 New Drug Approvals for Allergy Treatment Provide Lucrative Market Opportunity
5.3 Future Trends
- 5.3.1 Rising Research & Development (R&D) activities are likely to remain key trends in the market
5.4 Impact of Drivers and Restraints
6. North America Allergy Treatment Market Regional Analysis
6.1 North America Allergy Treatment Market Overview
6.2 North America Allergy Treatment Market Revenue 2018-2028 (US$ Million)
6.3 North America Allergy Treatment Market Forecast Analysis
7. North America Allergy Treatment Market Analysis – by Allergy Type
7.1 Eye Allergy
- 7.1.1 Overview
- 7.1.2 Eye Allergy: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Rhinitis
- 7.2.1 Overview
- 7.2.2 Rhinitis: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Asthma
- 7.3.1 Overview
- 7.3.2 Asthma: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Skin Allergy
- 7.4.1 Overview
- 7.4.2 Skin Allergy: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Food Allergies
- 7.5.1 Overview
- 7.5.2 Food Allergies: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Other Allergies
- 7.6.1 Overview
- 7.6.2 Other Allergies: North America Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Allergy Treatment Market Analysis – by Treatment
8.1 Anti-Allergy Drugs
- 8.1.1 Overview
- 8.1.2 Anti-Allergy Drugs: North America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Immunotherapy
- 8.2.1 Overview
- 8.2.2 Immunotherapy : North America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Allergy Treatment Market – North America Analysis
9.1 North America
- 9.1.1 North America Allergy Treatment Market Breakdown, by Key
Country, 2021 and 2028 (%)
- 9.1.1.1 North America Allergy Treatment Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Allergy Treatment Market Breakdown, by Allergy Type
- 9.1.1.1.2 US: North America Allergy Treatment Market Breakdown, by Treatment
- 9.1.1.2 Canada:
North America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Allergy Treatment Market Breakdown, by Allergy Type
- 9.1.1.2.2 Canada: North America Allergy Treatment Market Breakdown, by Treatment
- 9.1.1.3 Mexico :
North America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Allergy Treatment Market Breakdown, by Allergy Type
- 9.1.1.3.2 Mexico : North America Allergy Treatment Market Breakdown, by Treatment
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Allergy Treatment Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Johnson and Johnson Services, Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sanofi
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVie's Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ALK-Abelló A/S
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Allergy Therapeutics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Stallergenes Greer
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 GlaxoSmithKline PLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Allergy Treatment Market
